Effects of sugar derivatives on sleep
- Conditions
- not applicable
- Registration Number
- JPRN-UMIN000050077
- Lead Sponsor
- Clinical Creative Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 260
Not provided
(1) Who is currently receiving treatment (including medication) for any disease (2) In particular, those who have been diagnosed with sleep disorders such as insomnia or sleep apnea and are taking drugs such as sleep inducing drugs or insomnia medications (including OTC drugs as well as prescription drugs) or receiving treatment with CPAP, mouthpiece, etc. (3) In particular, those who have been diagnosed and treated for allergic diseases such as atopic dermatitis, asthma, allergic rhinitis, etc. (4) In particular, those who suffer from post-coronary syndrome (5) Those who regularly consume Food for Specified Health Use, Food with Functional Labeling, or other food/beverage with possible functionality (6) Those whose BMI exceeds 30 (severely obese) (7) Those who are mainly in charge of taking care of those who need nursing care or infants (8) Those who work late at night, shift work, or heavy labor (9) Those who are pregnant, lactating, or intend to become pregnant (10) Those who cannot sleep alone on a single bedding (futon or bed, etc.) during the examination period. (11) Those who are not able to comply with the gentle sleep control (going to bed within +-2 hours of the declared bedtime and waking up within +-2 hours of the declared waking time) during the examination period, or those who are not sleeping regularly. Items that cannot be listed in the key exclusion criterria column are listed in other related information.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method